Tomoaki Nakajima

The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease

Masahide Hamaguchi, Takao Kojima, Noriyuki Takeda et al. · Annals of Internal Medicine · 2005 · 1.1K citations

Medicine, Endocrinology, Hepatology +9

The Severity of Ultrasonographic Findings in Nonalcoholic Fatty Liver Disease Reflects the Metabolic Syndrome and Visceral Fat Accumulation

Masahide Hamaguchi, Takao Kojima, Yoshito Itoh et al. · The American Journal of Gastroenterology · 2007 · 925 citations

Veterinary Medicine, Internal Medicine, Radiology +17

Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD

Hirokazu Takahashi, Takaomi Kessoku, Miwa Kawanaka et al. · Hepatology Communications · 2021 · 149 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Activation of B‐Myb by E2F1 in hepatocellular carcinoma

Tomoaki Nakajima, Kohichiroh Yasui, Keika Zen et al. · Hepatology Research · 2008 · 64 citations

Life Sciences, Genetics, Molecular Biology +17

Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey

Katsutoshi Tokushige, Hideyuki Hyogo, Tomoaki Nakajima et al. · Journal of Gastroenterology · 2015 · 61 citations

Medicine, Oncology, Pathology +16